期刊文献+

无细胞百日咳疫苗特异性毒性检测方法现状及展望 被引量:1

Current status and prospect of specific methods for determination of toxicity of an aceilular pertussis vaccine
原文传递
导出
摘要 百日咳毒素是百日咳杆菌重要的保护性抗原,经化学方法脱毒成为百日咳类毒素后制成的无细胞百日咳疫苗(acellular pertussis vaccine,APV)具有残余毒性和毒性逆转的可能性,所以建立特异性毒性检测方法对于保证APV的安全性是十分必要的。此文就国内外APV特异性毒性检测方法的现状做一综述,并结合近几年国外研究的毒性检测新方法进行展望。 Pertussis toxin (PT) is a major protective antigen of Bordetella pertussis and its detoxified form obtained by a chemical process is an important component of an acellular pertussis vaccine (APV). In view of the possibility of residual toxicity or toxicity reversion of PT in the vaccines, specific tests are required to assure safety of the vaccines. This paper reviews specific methods for determination of toxicity of APV and prospect of new tests in the world.
出处 《国际生物制品学杂志》 CAS 2014年第3期137-140,共4页 International Journal of Biologicals
关键词 百日咳毒素 脱细胞百日咳疫苗 毒性试验 Pertussis toxin Acellular pertussis vaccine Toxicity tests
  • 相关文献

参考文献24

  • 1杨晓明.百日咳疫苗[M]∥李忠明.当代新疫苗.北京:高等教育出版社,2001:257-290.
  • 2何长民,杨晓明,陈平纡,陈爱荣,张蓉,程夷,边淑娟,吕桂荣.无细胞百日咳菌苗的抗原性和免疫原性研究[J].上海免疫学杂志,1991,11(5):289-293. 被引量:10
  • 3Rutter DA, Ashworth LA, Ddy A, et al. Trial of a new acel- lular pertussis vaccine in healthy adult volunteers[J]. Vaccine, 1988, 6(1): 29-32.
  • 4Tamura M, Nogimori K, Murai S, et al. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model [J]. Biochemistry, 1982, 21(22) :5516-5522.
  • 5Pizza M, Covacci A, Bartoloni A, et al. Mutants of pertussis toxin suitable for vaccine development[J]. Science, 1989, 246 (4929) :497-500.
  • 6Halperin SA, Issekutz TB, Kasina A. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin [J]. J Infect Dis, 1991, 163(2) :355-361.
  • 7Carbonetti NH, Artamonova GV, Andreasen C, et al. Per- tussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tract[J]. Infect Immun, 2005, 73 (5):2698- 2703.
  • 8Gillenius P, Jitmaa E, Askel6I P, et al. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells [J]. J Biol Stand, 1985, 13 (l): 61-66.
  • 9张霖阳,潘殊男,李世慧,徐鹤,周峻凯,肖詹蓉.检测百日咳毒素活性的中国仓鼠卵巢细胞簇集法的建立和初步应用[J].国际生物制品学杂志,2013,36(4):177-181. 被引量:5
  • 10Corbel MJ, Xinn DK. Toxicity and potency evaluation of pertussis vaccines[J]. Expert Rev Vaccines, 2004, 3(l) :89-101.

二级参考文献21

  • 1张庶民,徐颖华.我国百日咳疫苗现状及展望[J].中国药事,2005,19(11):685-688. 被引量:14
  • 2侯启明,张庶民,梁雅文,张路民,项美娟,蒋强华,肖詹荣,付春晖,吴玫,刘志强,孟丽,李松,金于兰,冯洁,陈晓婷,孙晓林.第一代无细胞百日咳疫苗毒性国家参考品制备工艺的研究[J].药品评价,2005,2(6):423-424. 被引量:2
  • 3杨瑜(综述),朱为(审校).百日咳毒素在疫苗中的研究现状及应用[J].国际生物制品学杂志,2007,30(4):156-159. 被引量:2
  • 4国家药典委员会.中国药典(三部)[s].北京:中国医药科技出版社,2010:111-114.
  • 5侯启明,张路民,梁雅文,秦进才.应用CHO细胞法检测百日咳疫苗中的残余毒性[J].中国生物制品学杂志,1997,10(2):101-103. 被引量:4
  • 6Gillenius P, Jaatmaa E, Askelof P, et al. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells [ J]. J Biol Stand, 1985, 13 ( 1 ) : 61-66.
  • 7Xing D, Yuen CT, Asokanathan C, et al. Evaluation of an in vitro assay system as a potential alternative to current histamine sensitization test for acellular pertussis vaccines [ J]. Biologicals, 2012, 40(6) : 456-465.
  • 8Arciniega JL, Corbel M, Dellepiane N, et al. WHO guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines [ J ]. Biologicals, 1998, 26(3) : 195-204.
  • 9Xing D, Das RG, Newland P, et al. Comparison of the bioactivity of reference preparations for assaying Bordetella pertussis toxin activity in vaccines by the histamine sensitisation and Chinese hamster ovary-cell tests: assessment of validity of expression of activity in terms of protein concentration [ J ]. Vaccine, 2002, 20 (29/30) : 3535-3542.
  • 10WHO. WHO Technical Report Series 878: Acellular vaccines JR]. 1998.

共引文献14

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部